STOCK TITAN

ANAB (NASDAQ: ANAB) insider files Form 144 to sell 7,622 shares total

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Eric J. Loumeau filed a Form 144 notice covering a planned sale of 7,622 shares of ANAB common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $348,212.59. The shares are part of restricted stock awards acquired on January 3, 2025 (4,294 shares) and January 6, 2025 (3,328 shares), both from the issuer.

Over the prior three months, the notice lists multiple sales of ANAB common stock by Loumeau, including 10,000 shares sold on December 17, 2025 for $460,000.00, another 10,000 shares on December 22, 2025 for $510,000.00, and 12,500 shares on December 16, 2025 for $560,800.25, plus smaller transactions. The form also includes a representation that the seller does not know of undisclosed material adverse information about ANAB.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ANAB disclose?

The Form 144 discloses that Eric J. Loumeau intends to sell 7,622 shares of ANAB common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $348,212.59.

How many ANAB shares is the insider planning to sell under this Form 144?

The filing shows a planned sale of 7,622 shares of ANAB common stock, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

When and how were the ANAB shares in this Form 144 acquired?

The shares were acquired as restricted stock from the issuer on January 3, 2025 (4,294 shares) and January 6, 2025 (3,328 shares), with payment noted as Not Applicable in the form.

What recent ANAB stock sales by Eric J. Loumeau are listed in the past 3 months?

The notice lists several recent sales of ANAB common stock, including 12,500 shares on December 16, 2025 for $560,800.25, 10,000 shares on December 17, 2025 for $460,000.00, and 10,000 shares on December 22, 2025 for $510,000.00, plus smaller trades.

Which broker is handling the planned ANAB share sale in this Form 144?

The planned sale of 7,622 ANAB common shares is listed as being through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY, on NASDAQ.

What representation does the seller make in the ANAB Form 144 notice?

The seller represents that he does not know any material adverse information about the current and prospective operations of ANAB that has not been publicly disclosed.
Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.33B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO